We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pathology Checklist a First for Next Generation Sequencing Laboratory Standards

By LabMedica International staff writers
Posted on 20 Aug 2012
A gold standard molecular pathology checklist has been revised to include a dedicated section on next generation sequencing (NGS), the first published laboratory accreditation checklist that addresses NGS, advancing standardized practice in genomic testing.

The College of American Pathologists (CAP; Northfield, IL, USA), the largest association of board-certified pathologists and a global leader in laboratory quality assurance, has now published the new edition of the CAP Laboratory Accreditation Program checklists, released July 31, 2012. More...
CAP checklists are used to guide accreditation of more than 7,000 laboratories in the US and abroad.

“Pathologists, trained to provide medical direction of NGS testing, and the CAP, experienced in laboratory quality assurance programs, are not only leading this NGS initiative, but collaborating with other medical organizations to advance the science of genomic medicine,” said Karl V. Voelkerding, MD, FCAP, professor of Pathology at the University of Utah, and Medical Director for Genomics and Bioinformatics at ARUP Laboratories (Salt Lake City, UT, USA). Dr. Voelkerding led the CAP working group that created the NGS section of the molecular pathology checklist. The new NGS section has 18 requirements that address the analytical wet bench process including conversion of DNA into a NGS library followed by sequencing, and the subsequent bioinformatics analyses comprised of sequence alignment and mapping, variant calling, and annotation.

“The publication of this checklist demonstrates CAP’s leadership in advancing standards of practice in genomic medicine,” said Nazneen Aziz, PhD, director of Molecular Medicine and staff lead for the CAP’s NGS Working Group. “The workgroup was judicious in developing the requirements by creating the necessary framework for clinical testing using NGS and yet not being overly prescriptive to accommodate the differences in the technology platforms and the growth of the rapidly evolving technology”.

The CAP’s efforts to further advance clinical testing using NGS go beyond accreditation and will include development of NGS proficiency testing products in the near future. The CAP supports and continues to work with other organizations, including the American College of Medical Genetics and Genomics (ACMG), the Association for Molecular Pathology (AMP), and Health Level 7 (HL-7), to develop standards for reporting genetic variants, for their interpretation for clinical use and interoperability of results in healthcare information systems.

Related Links:

College of American Pathologists
ARUP Laboratories




New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Pan-Cancer Panel
TruSight Oncology 500
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.